Malignant tumor
Conditions
Interventions
experimental group:Oral Qi Xue Kang oral liquid
control group:Oral Qi Xue Kang oral liquid placebo
Sponsors
Wangjing Hospital of Chinese Academy of science of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. aged 18~75 years, male and female; 2. malignant solid tumor (according to the TNM staging system of the UICC), the tumor type is limited to four types of lung cancer, breast cancer, colorectal cancer and gastric cancer; 3. ECOG score less than 2; 4. before chemoradiotherapy, WBC was more than 4x10^9/L, neutrophils were more than 2 x 10^9/L, and PLT was more than 100x10^9/L; 5. no severe heart, lung, liver, kidney and bone marrow dysfunction; 6. the expected survival to be longer than 3 months; 7. Be willing to cooperate with the trial protocol and with good compliance; 8. voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. patients with multiple bone metastases; 2. patients who are allergic to any test drugs and their adjuvants; 3. alcoholics and drug addicts, with epilepsy or mental disorders; 4. pregnant, lactation, or planned gestation; 5. participating in or participated in other clinical trials within past 3 months; 6. the researchers believe the patient not suitable for the study (such as those with poor glucose control).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| white blood cell; | — |
Secondary
| Measure | Time frame |
|---|---|
| Red blood cell;Platelet;hemoglobin;Neutrophils;Quality of life score;Fatigue scale;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactShijie ZHU
Wangjing Hospital of Chinese Academy of science of traditional Chinese Medicine
Outcome results
None listed